Earnings History Data for Amneal Pharmaceuticals (AMRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amneal Pharmaceuticals

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-05-2022	PM	6:00 AM ET (May 4)	AMRX	Amneal Pharmaceuticals	1,164	0.10	0.12	0.00	Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M [5/4/2022 6:05 AM]	3.73	-0.28 (-6.86%)	3.85	-0.16 (-3.99%)	3.26 - 6.21	2,505,315	640,000	7,830
Amneal Pharmaceuticals Q1 2022 Earnings Preview [5/3/2022 11:18 AM] Amneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66M [5/4/2022 6:05 AM] Amneal falls 12% on disappointing Q1 result [5/4/2022 1:41 PM] Amneal Reports First Quarter 2022 Financial Results [May-04-22 06:00AM] Amneal Pharmaceuticals (AMRX) Q1 Earnings Meet Estimates [May-04-22 07:25AM]
02-03-2022	PM	6:00 AM ET (Mar 2)	AMRX	Amneal Pharmaceuticals, Inc.	676.65	0.16	0.17	0.11	Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M [3/2/2022 6:02 AM]	4.04	-0.41 (-9.33%)	4.30	-0.15 (-3.37%)	3.89 - 7.45	1,537,047	450,000	6,722
Amneal Pharmaceuticals Q4 2021 Earnings Preview [3/1/2022 12:29 PM] Amneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59M [3/2/2022 6:02 AM] Amneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimates [3/2/2022 12:09 PM] Amneal Enters U.S. Biosimilars Market With Approval of RELEUKOTM (filgrastim-ayow) [Mar-01-22 04:05PM] Amneal Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-02-22 06:00AM] Amneal Pharmaceuticals (AMRX) Lags Q4 Earnings Estimates [Mar-02-22 07:25AM]
03-11-2021	PM	6:00 AM ET (Nov 3)	AMRX	Amneal Pharmaceuticals	1,670	0.19	0.20	0.00	Amneal Pharmaceuticals EPS beats by $0.01, misses on revenue [11/3/2021 6:01 AM]	5.30	-0.51 (-8.85%)	5.50	-0.32 (-5.50%)	3.90 - 7.45	1,665,983	700,000	9,841
Amneal Pharmaceuticals EPS beats by $0.01, misses on revenue [11/3/2021 6:01 AM] Amneal Pharmaceuticals Q3 2021 Earnings Preview [11/2/2021 10:25 AM] Amneal Reports Third Quarter 2021 Financial Results [Nov-03-21 06:00AM] Amneal Releases Inaugural Corporate Responsibility Report Highlighting Our Impact as a Socially Responsible Company [Nov-02-21 08:00AM] Amneal Pharmaceuticals (AMRX) Tops Q3 Earnings Estimates [Nov-03-21 07:25AM] Amneal Pharmaceuticals, inc (AMRX) Q3 2021 Earnings Call Transcript [Nov-03-21 04:01PM]
09-08-2021	PM	6:00 AM ET (Aug 9)	AMRX	Amneal Pharmaceuticals, Inc.	748.06	0.23	0.18	0.10	Amneal Pharmaceuticals EPS beats by $0.06, beats on revenue [8/9/2021 6:03 AM]	5.14	0.27 (5.54%)	5.15	0.28 (5.75%)	3.45 - 7.45	1,549,183	730,000	6,703
Amneal Pharmaceuticals EPS beats by $0.06, beats on revenue [8/9/2021 6:03 AM] Amneal Reports Second Quarter 2021 Financial Results [Aug-09-21 06:00AM] Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Top Estimates [Aug-09-21 07:25AM] Amneal Pharmaceuticals, inc (AMRX) Q2 2021 Earnings Call Transcript [Aug-09-21 01:30PM]
07-05-2021	PM	6:00 AM ET (May 7)	AMRX	Amneal Pharmaceuticals, Inc.	847.52	0.19	0.17	0.18	Amneal Pharmaceuticals EPS beats by $0.02, misses on revenue [5/7/2021 6:06 AM]	5.20	-0.58 (-10.03%)	5.20	0.0 (0.00%)	3.44 - 7.45	2,375,046	970,000	961
Amneal Pharmaceuticals Q1 2021 Earnings Preview [5/6/2021 11:47 AM] Amneal Pharmaceuticals EPS beats by $0.02, misses on revenue [5/7/2021 6:06 AM] Amneal Reports First Quarter 2021 Financial Results [May-07-21 06:00AM] Amneal Pharmaceuticals, Inc. to Host Earnings Call [May-07-21 06:45AM] Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates [May-07-21 07:30AM] Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcript [May-07-21 06:00PM]
26-02-2021	PM	6:00 AM ET (Feb 26)	AMRX	Amneal Pharmaceuticals, Inc.	708.62	0.11	0.12	0.07	Amneal Pharmaceuticals EPS beats by $0.01, beats on revenue [2/26/2021 6:05 AM]	5.44	0.55 (11.25%)	5.00	0.11 (2.25%)	2.40 - 6.18	4,109,256	1,384,050	22,277
Amneal Pharmaceuticals EPS beats by $0.01, beats on revenue [2/26/2021 6:05 AM] Amneal Pharmaceuticals Q4 2020 Earnings Preview [2/25/2021 12:00 PM] Amneal wins FDA nod for generic version of Ortho Evra [2/26/2021 7:23 AM] Amneal shares rise after Q4 results, FY forecast [2/26/2021 8:08 AM] Amneal Pharmaceuticals (AMRX) Surpasses Q4 Earnings and Revenue Estimates [Feb-26-21 07:30AM] Amneal Pharmaceuticals, Inc. to Host Earnings Call [Feb-26-21 06:30AM] Amneal Receives Approval for Generic Version of Ortho Evra® [Feb-26-21 06:02AM] Amneal Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-26-21 06:00AM] A Preview Of Amneal Pharmaceuticals's Earnings [Feb-25-21 10:04AM]
06-11-2020	PM	6:00 AM ET (Nov 6)	AMRX	Amneal Pharmaceuticals, Inc.	708.19	0.13	0.12	0.00	Amneal Pharmaceuticals EPS beats by $0.04, beats on revenue [11/6/2020 6:01 AM]	4.12	-0.80 (-16.33%)	4.99	0.06 (1.22%)	2.40 - 5.79	2,640,012	1,411,449	29,264

06-08-2020	PM	6:30 AM ET (Aug 6)	AMRX	Amneal Pharmaceuticals, Inc.	1,410	0.10	0.10	0.06	Amneal Pharmaceuticals EPS beats by $0.03, beats on revenue [8/6/2020 6:06 AM]	4.63	-0.64 (-12.14%)	4.54	-0.73 (-13.85%)	2.27 - 5.79	1,802,723	1,226,651	73,460